Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis

The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mult Scler
Main Authors: Motl, Robert W, Cohen, Jeffrey A, Benedict, Ralph, Phillips, Glenn, LaRocca, Nicholas, Hudson, Lynn D, Rudick, Richard
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2017
Assuntos:
Invited Reviews
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5405807/
https://ncbi.nlm.nih.gov/pubmed/28206828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517690823
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares